LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it has decided to ...
SMBs have the same intelligence needs as enterprises. They need clarity, speed, and confidence in their data. The Voyager program and Mission Control Network allows us to deliver those capabilities.” ...
VY1706 and NBIB-‘233 completed IND-enabling GLP toxicology; clinical entry expected H2 2026 -- Multiple presentations at ...
The Daily Galaxy on MSN
After 50 years in space, Voyager 1 becomes the first human-made object to travel one full light-day from Earth
In November 2026, NASA’s Voyager 1 spacecraft will become the first human-made object to travel a full light-day from Earth. Nearly 50 years after its launch, this milestone highlights the vastness of ...
'We realize that Voyager means a lot to people and we are doing our best to keep them going for as long as possible.' By Andrew Paul Published Dec 14, 2023 11:35 AM EST Add Popular Science (opens in a ...
For nearly five decades, NASA's twin Voyager probes have plumbed the cosmos in search of answers to some of astronomy's most perplexing mysteries about our solar system and its place in the wider ...
- All other programs remain on track; IND filings expected in 2025 for GBA1 and FA programs - LEXINGTON, Mass., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (VYGR), a biotechnology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results